INTERNATIONAL PATENT: FUNDACION PARA LA INVESTIGACION BIOMEDICA DEL HOSPITAL UNIVERSITARIO RAMON Y CAJAL FILES APPLICATION FOR "SNFL AND SGFAP LEVELS AS PREDICTIVE BIOMARKERS FOR TREATMENT RESPONSE IN RELAPSING MS PATIENTS TREATED WITH OCRELIZUMAB"

GENEVA, April 19 -- FUNDACION PARA LA INVESTIGACION BIOMEDICA DEL HOSPITAL UNIVERSITARIO RAMON Y CAJAL (Carretera de Colmenar Viejo Km. 9.100 planta -2 derecha28034 Madrid) filed a patent application (PCT/EP2024/078404) for "SNFL AND SGFAP LEVELS AS PREDICTIVE BIOMARKERS FOR TREATMENT RESPONSE IN RELAPSING MS PATIENTS TREATED WITH OCRELIZUMAB" on Oct 09, 2024. With publication no. WO/2025/078434, the details related to the patent application was published on Apr 17, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): VILLAR GUIMERANS, Maria Luisa (FUNDACION PARA LA INVESTIGACION BIOMEDICA DEL HO...